Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mari Wang"'
Autor:
Gunnar Eliassen, Olbjørn Klepp, Sophie D. Fosså, Haakon. Melsom, Mari. Wang, Ragna Følling Elgjo, Tomas. Urnes
Publikováno v:
International journal of andrology. 4
In 103 patients with malignant germ cell tumours the initial clinical diagnosis was incorrect in 45 (44%). The correct diagnosis was established within 2 months in only 31% of the patients, and delayed by more than 6 months in 27%. Stage, distributio
Autor:
Trond Eirik Strand, Stein Sundstrøm, Jarle Norstein, Andreas Stensvold, Kjersti Hornslien, Mari Wang, Paal Brunsvig, Oddveig Garpestad, Roy M. Bremnes, Dag Clement Johannessen
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 80:133-141
Purpose: The efficacy of curative irradiation in the treatment of non-small-cell lung cancer patients is considered limited. The purpose of this study was to evaluate long-term survival in a population-based approach. Methods and Materials: Cases of
Autor:
Grethe Lauvvang, Mari Wang, Reidulv Hatlevoll, Steinar Aamdal, Randi Berg, Kristin Øwre, P. Brunsvig
Publikováno v:
Lung Cancer. 50:97-105
Summary This Phase I/II study investigated weekly docetaxel (Taxotere ® ) with concurrent radiotherapy in 42 patients with untreated stage III non-small cell lung cancer (NSCLC). All patients were treated with chest irradiation: 2Gy administered 5 d
Autor:
Steinar Aamdal, Stein Kaasa, Tor Vigander, Ulf Aasebø, Ragnar Dahle, Reidulv Hatlevoll, Eva Skovlund, Roy M. Bremnes, Mari Wang, Jan Vilsvik, Stein Sundstrøm, Einar Hannisdal, Nils Boye
Publikováno v:
Journal of Clinical Oncology. 20:4665-4672
PURPOSE: To investigate whether chemotherapy with etoposide and cisplatin (EP) is superior to cyclophosphamide, epirubicin, and vincristine (CEV) in small-cell lung cancer (SCLC). PATIENTS AND METHODS: A total of 436 eligible patients were randomized
Autor:
Roy M. Bremnes, Christian von Plessen, P. Brunsvig, Stein Sundstrøm, Mari Wang, Øystein Fløtten, Bjørn Henning Grønberg, Ulf Aasebø, Tore Amundsen
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 63(1)
To investigate the efficacy and tolerability of high-dose pemetrexed as second-line chemotherapy in small cell lung cancer (SCLC).Patients with verified SCLC who had received one prior chemotherapy regimen, aged 18-75 years, WHO Performance Status 0-
Autor:
Mari Wang
Publikováno v:
Tidsskrift for Den norske legeforening. 130:1450-1450
Autor:
Bjørn Henning Grønberg, Mari Wang, Gunnar Hillerdal, H. Riska, Hans Garmo, Stein Sundstrøm, Gunnar Wagenius, Jan Nyman, G. Greim, O. Brodin
Publikováno v:
Journal of Clinical Oncology. 24:7136-7136
7136 Background: Metastasis to the brain is the most common intracranial tumour and 20–40% of all cancer patients will develop brain metastases. Lung cancer is the most common primary tumour and compose of 40%-50% of all brain metasases. As the sur
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.